Eissenberg T - Search Results

1

Electronic cigarettes: what are they and what do they do?

Breland A, Soule E, Lopez A, Ramôa C, El-Hellani A, Eissenberg T. Breland A, et al. Among authors: eissenberg t. Ann N Y Acad Sci. 2017 Apr;1394(1):5-30. doi: 10.1111/nyas.12977. Epub 2016 Jan 15. Ann N Y Acad Sci. 2017. PMID: 26774031 Free PMC article. Review.

2

Acute effects of Advance: a potential reduced exposure product for smokers.

Breland AB, Evans SE, Buchhalter AR, Eissenberg T. Breland AB, et al. Among authors: eissenberg t. Tob Control. 2002 Dec;11(4):376-8. doi: 10.1136/tc.11.4.376. Tob Control. 2002. PMID: 12432165 Free PMC article.

3

Evaluating acute effects of potential reduced-exposure products for smokers: clinical laboratory methodology.

Breland AB, Buchhalter AR, Evans SE, Eissenberg T. Breland AB, et al. Among authors: eissenberg t. Nicotine Tob Res. 2002;4 Suppl 2:S131-40. doi: 10.1080/1462220021000032780. Nicotine Tob Res. 2002. PMID: 12573174 Clinical Trial.

4

Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of Advance.

Breland AB, Acosta MC, Eissenberg T. Breland AB, et al. Among authors: eissenberg t. Tob Control. 2003 Sep;12(3):317-21. doi: 10.1136/tc.12.3.317. Tob Control. 2003. PMID: 12958395 Free PMC article. Clinical Trial.

5

Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography/mass spectrometry and immunoassay test strips.

Acosta M, Buchhalter A, Breland A, Hamilton D, Eissenberg T. Acosta M, et al. Among authors: eissenberg t. Nicotine Tob Res. 2004 Aug;6(4):615-20. doi: 10.1080/14622200410001727867. Nicotine Tob Res. 2004. PMID: 15370157 Clinical Trial.

6

Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes.

Buchhalter AR, Acosta MC, Evans SE, Breland AB, Eissenberg T. Buchhalter AR, et al. Among authors: eissenberg t. Addiction. 2005 Apr;100(4):550-9. doi: 10.1111/j.1360-0443.2005.01030.x. Addiction. 2005. PMID: 15784070 Clinical Trial.

7

Clinical laboratory evaluation of potential reduced exposure products for smokers.

Breland AB, Kleykamp BA, Eissenberg T. Breland AB, et al. Among authors: eissenberg t. Nicotine Tob Res. 2006 Dec;8(6):727-38. doi: 10.1080/14622200600789585. Nicotine Tob Res. 2006. PMID: 17132520

8

Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.

Gray JN, Breland AB, Weaver M, Eissenberg T. Gray JN, et al. Among authors: eissenberg t. Nicotine Tob Res. 2008 Sep;10(9):1441-8. doi: 10.1080/14622200802323258. Nicotine Tob Res. 2008. PMID: 19023835 Free PMC article. Clinical Trial.

9

Clinical laboratory assessment of the abuse liability of an electronic cigarette.

Vansickel AR, Weaver MF, Eissenberg T. Vansickel AR, et al. Among authors: eissenberg t. Addiction. 2012 Aug;107(8):1493-500. doi: 10.1111/j.1360-0443.2012.03791.x. Epub 2012 May 8. Addiction. 2012. PMID: 22229871 Free PMC article.

10

Electronic cigarettes: effective nicotine delivery after acute administration.

Vansickel AR, Eissenberg T. Vansickel AR, et al. Among authors: eissenberg t. Nicotine Tob Res. 2013 Jan;15(1):267-70. doi: 10.1093/ntr/ntr316. Epub 2012 Feb 6. Nicotine Tob Res. 2013. PMID: 22311962 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters